Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nu Skin Enterprises, Inc. (NUS) since 2012 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nu Skin Enterprises, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1021561.
Total stock buying since 2012: $2,518,326.
Total stock sales since 2012: $180,477,160.
Total stock option exercises since 2012: $111,724,176.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 6,500 | $49,010 | 60,619 | $724,593 | 0 | $0 |
| 2024 | 0 | $0 | 11,693 | $158,349 | 0 | $0 |
| 2023 | 0 | $0 | 222,108 | $8,289,574 | 164,194 | $5,019,955 |
| 2022 | 0 | $0 | 236,968 | $10,496,281 | 119,423 | $4,005,422 |
| 2021 | 40,870 | $2,004,026 | 113,695 | $6,184,296 | 102,402 | $3,134,952 |
| 2020 | 10,000 | $202,500 | 134,863 | $6,553,944 | 73,400 | $2,308,625 |
| 2019 | 0 | $0 | 1,250 | $75,750 | 103,950 | $4,069,067 |
| 2018 | 0 | $0 | 1,741,867 | $122,631,723 | 1,687,252 | $76,802,735 |
| 2017 | 0 | $0 | 246,966 | $15,917,519 | 258,688 | $7,494,683 |
| 2016 | 7,500 | $249,900 | 131,000 | $7,766,656 | 422,250 | $4,468,645 |
| 2015 | 0 | $0 | 36,250 | $1,678,475 | 241,000 | $4,420,092 |
| 2012 | 218 | $12,890 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-09 | 0 | $0 | 26,489 | $318,695 | 0 | $0 |
| 2025-08 | 0 | $0 | 32,437 | $392,812 | 0 | $0 |
| 2025-05 | 6,500 | $49,010 | 0 | $0 | 0 | $0 |
| 2025-02 | 0 | $0 | 1,693 | $13,086 | 0 | $0 |
| 2024-05 | 0 | $0 | 3,693 | $47,009 | 0 | $0 |
| 2024-04 | 0 | $0 | 2,000 | $24,680 | 0 | $0 |
| 2024-03 | 0 | $0 | 2,000 | $24,640 | 0 | $0 |
| 2024-02 | 0 | $0 | 2,000 | $24,920 | 0 | $0 |
| 2024-01 | 0 | $0 | 2,000 | $37,100 | 0 | $0 |
| 2023-12 | 0 | $0 | 2,000 | $38,780 | 0 | $0 |
| 2023-11 | 0 | $0 | 17,400 | $306,492 | 0 | $0 |
| 2023-10 | 0 | $0 | 2,000 | $38,460 | 0 | $0 |
| 2023-09 | 0 | $0 | 2,000 | $46,040 | 0 | $0 |
| 2023-08 | 0 | $0 | 9,340 | $226,282 | 0 | $0 |
| 2023-07 | 0 | $0 | 2,000 | $57,980 | 0 | $0 |
| 2023-06 | 0 | $0 | 2,000 | $64,239 | 0 | $0 |
| 2023-05 | 0 | $0 | 3,255 | $116,086 | 0 | $0 |
| 2023-04 | 0 | $0 | 2,000 | $81,500 | 0 | $0 |
| 2023-03 | 0 | $0 | 142,784 | $5,775,583 | 132,681 | $4,054,712 |
| 2023-02 | 0 | $0 | 36,329 | $1,495,862 | 31,513 | $965,243 |
| 2023-01 | 0 | $0 | 1,000 | $42,270 | 0 | $0 |
| 2022-11 | 0 | $0 | 26,000 | $999,410 | 25,000 | $852,624 |
| 2022-10 | 0 | $0 | 1,000 | $35,920 | 0 | $0 |
| 2022-09 | 0 | $0 | 2,602 | $99,452 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-04 | Nathanson Laura (Director) | Sale | 6,489 | 12.22 | 79,295 |
| 2025-09-03 | Clark Chayce David (EVP and General Counsel) | Sale | 20,000 | 11.97 | 239,400 |
| 2025-08-29 | Campbell Daniel W (Director) | Sale | 32,437 | 12.11 | 392,812 |
| 2025-05-28 | Hatchett Steven Keith (Chief Product Officer) | Buy | 6,500 | 7.54 | 49,010 |
| 2025-02-21 | Battle Emma S. (Director) | Sale | 1,693 | 7.73 | 13,086 |
| 2024-05-28 | Lipman Andrew D (Director) | Sale | 2,000 | 13.33 | 26,660 |
| 2024-05-02 | Woodbury Edwina D (Director) | Sale | 1,693 | 12.02 | 20,349 |
| 2024-04-25 | Lipman Andrew D (Director) | Sale | 2,000 | 12.34 | 24,680 |
| 2024-03-25 | Lipman Andrew D (Director) | Sale | 2,000 | 12.32 | 24,640 |
| 2024-02-26 | Lipman Andrew D (Director) | Sale | 2,000 | 12.46 | 24,920 |
| 2024-01-25 | Lipman Andrew D (Director) | Sale | 2,000 | 18.55 | 37,100 |
| 2023-12-26 | Lipman Andrew D (Director) | Sale | 2,000 | 19.39 | 38,780 |
| 2023-11-27 | Lipman Andrew D (Director) | Sale | 2,000 | 17.11 | 34,220 |
| 2023-11-03 | Lipman Andrew D (Director) | Sale | 15,400 | 17.68 | 272,272 |
| 2023-10-25 | Lipman Andrew D (Director) | Sale | 2,000 | 19.23 | 38,460 |
| 2023-09-25 | Lipman Andrew D (Director) | Sale | 2,000 | 23.02 | 46,040 |
| 2023-08-25 | Lipman Andrew D (Director) | Sale | 2,000 | 23.33 | 46,660 |
| 2023-08-21 | Nathanson Laura (Director) | Sale | 6,068 | 24.12 | 146,360 |
| 2023-08-07 | Battle Emma S. (Director) | Sale | 1,272 | 26.15 | 33,262 |
| 2023-07-25 | Lipman Andrew D (Director) | Sale | 2,000 | 28.99 | 57,980 |
| 2023-06-26 | Lipman Andrew D (Director) | Sale | 2,000 | 32.12 | 64,239 |
| 2023-05-25 | Lipman Andrew D (Director) | Sale | 2,000 | 34.28 | 68,560 |
| 2023-05-09 | Woodbury Edwina D (Director) | Sale | 1,255 | 37.87 | 47,526 |
| 2023-04-25 | Lipman Andrew D (Director) | Sale | 2,000 | 40.75 | 81,500 |
| 2023-03-27 | Lipman Andrew D (Director) | Sale | 2,000 | 39.29 | 78,580 |
| 2023-03-09 | Hatchett Steven Keith (Chief Product Officer) | Sale | 21,155 | 39.78 | 841,545 |
| 2023-03-09 | Hatchett Steven Keith (Chief Product Officer) | Option Ex | 21,155 | 30.45 | 644,169 |
| 2023-03-02 | Lawrence Mark H (Chief Financial Officer) | Sale | 26,144 | 40.80 | 1,066,675 |
| 2023-03-02 | Lawrence Mark H (Chief Financial Officer) | Option Ex | 18,041 | 30.45 | 549,348 |
| 2023-03-02 | Chang Joseph Y (Chief Scientific Officer) | Sale | 25,000 | 40.77 | 1,019,250 |
| 2023-03-02 | Chang Joseph Y (Chief Scientific Officer) | Option Ex | 25,000 | 30.54 | 763,500 |
| 2023-03-01 | Chang Joseph Y (Chief Scientific Officer) | Sale | 68,485 | 40.44 | 2,769,533 |
| 2023-03-01 | Chang Joseph Y (Chief Scientific Officer) | Option Ex | 68,485 | 30.63 | 2,097,695 |
| 2023-02-28 | Napierski Ryan S (President and CEO) | Sale | 10,000 | 40.67 | 406,750 |
| 2023-02-28 | Napierski Ryan S (President and CEO) | Option Ex | 10,000 | 30.63 | 306,300 |
| 2023-02-27 | Napierski Ryan S (President and CEO) | Sale | 21,513 | 41.38 | 890,207 |
| 2023-02-27 | Napierski Ryan S (President and CEO) | Option Ex | 21,513 | 30.63 | 658,943 |
| 2023-02-23 | Thomas James D (Chief Accounting Officer) | Sale | 2,829 | 41.12 | 116,328 |
| 2023-02-22 | Battle Emma S. (Director) | Sale | 987 | 41.70 | 41,157 |
| 2023-02-22 | Lipman Andrew D (Director) | Sale | 1,000 | 41.42 | 41,420 |
| 2023-01-23 | Lipman Andrew D (Director) | Sale | 1,000 | 42.27 | 42,270 |
| 2022-11-25 | Napierski Ryan S (President and CEO) | Sale | 25,000 | 38.45 | 961,250 |
| 2022-11-25 | Napierski Ryan S (President and CEO) | Option Ex | 25,000 | 34.10 | 852,624 |
| 2022-11-22 | Lipman Andrew D (Director) | Sale | 1,000 | 38.16 | 38,160 |
| 2022-10-21 | Lipman Andrew D (Director) | Sale | 1,000 | 35.92 | 35,920 |
| 2022-09-22 | Lipman Andrew D (Director) | Sale | 1,000 | 36.67 | 36,670 |
| 2022-09-07 | Thomas James D (Chief Accounting Officer) | Sale | 1,602 | 39.19 | 62,782 |
| 2022-08-25 | Napierski Ryan S (President and CEO) | Sale | 25,000 | 42.99 | 1,074,750 |
| 2022-08-25 | Napierski Ryan S (President and CEO) | Option Ex | 25,000 | 34.10 | 852,624 |
| 2022-08-22 | Lipman Andrew D (Director) | Sale | 1,000 | 45.01 | 45,010 |
| 2022-07-22 | Lipman Andrew D (Director) | Sale | 1,000 | 43.00 | 43,000 |
| 2022-06-23 | Lund Steven (Exec. Chairman of the Board) | Sale | 17,129 | 45.11 | 772,689 |
| 2022-06-22 | Lipman Andrew D (Director) | Sale | 1,000 | 44.06 | 44,060 |
| 2022-06-22 | Lund Steven (Exec. Chairman of the Board) | Sale | 800 | 45.01 | 36,008 |
| 2022-06-21 | Lund Steven (Exec. Chairman of the Board) | Sale | 6,426 | 45.02 | 289,298 |
| 2022-06-17 | Lund Steven (Exec. Chairman of the Board) | Sale | 900 | 45.02 | 40,513 |
| 2022-06-15 | Lund Steven (Exec. Chairman of the Board) | Sale | 395 | 45.00 | 17,775 |
| 2022-06-13 | Lund Steven (Exec. Chairman of the Board) | Sale | 51,300 | 44.14 | 2,264,535 |
| 2022-06-06 | Lawrence Mark H (Chief Financial Officer) | Sale | 5,868 | 47.03 | 275,972 |
| 2022-06-01 | Chang Joseph Y (Chief Scientific Officer) | Sale | 16,000 | 46.61 | 745,760 |
| 2022-06-01 | Chang Joseph Y (Chief Scientific Officer) | Option Ex | 16,000 | 30.63 | 490,080 |
| 2022-05-25 | Napierski Ryan S (President and CEO) | Sale | 25,000 | 44.84 | 1,121,000 |
| 2022-05-25 | Napierski Ryan S (President and CEO) | Option Ex | 25,000 | 34.10 | 852,624 |
| 2022-05-23 | Lipman Andrew D (Director) | Sale | 1,000 | 44.95 | 44,950 |
| 2022-05-18 | Lund Steven (Exec. Chairman of the Board) | Sale | 925 | 46.07 | 42,614 |
| 2022-05-16 | Lund Steven (Exec. Chairman of the Board) | Sale | 21,200 | 45.25 | 959,300 |
| 2022-04-22 | Lipman Andrew D (Director) | Sale | 1,000 | 47.72 | 47,720 |
| 2022-03-22 | Lipman Andrew D (Director) | Sale | 1,000 | 47.40 | 47,400 |
| 2022-03-02 | Chang Joseph Y (Chief Scientific Officer) | Sale | 3,423 | 46.20 | 158,125 |
| 2022-03-02 | Chang Joseph Y (Chief Scientific Officer) | Option Ex | 3,423 | 30.63 | 104,846 |
| 2022-02-25 | Napierski Ryan S (President and CEO) | Sale | 25,000 | 47.49 | 1,187,250 |
| 2022-02-25 | Napierski Ryan S (President and CEO) | Option Ex | 25,000 | 34.10 | 852,624 |
| 2022-02-22 | Lipman Andrew D (Director) | Sale | 1,000 | 53.27 | 53,270 |
| 2022-01-24 | Lipman Andrew D (Director) | Sale | 1,000 | 50.50 | 50,500 |
| 2021-10-05 | Bettinger Jeffrey Clark (SVP, People and Places Officer) | Sale | 1,625 | 41.10 | 66,787 |
| 2021-09-13 | Chang Joseph Y (EVP, Chief Scientific Officer) | Sale | 16,000 | 47.41 | 758,560 |
| 2021-09-13 | Chang Joseph Y (EVP, Chief Scientific Officer) | Option Ex | 16,000 | 30.63 | 490,080 |
| 2021-07-02 | Dorny D Matthew (General Counsel) | Sale | 6,200 | 57.09 | 353,927 |
| 2021-07-02 | Dorny D Matthew (General Counsel) | Option Ex | 6,200 | 30.63 | 189,906 |
| 2021-06-01 | Dorny D Matthew (General Counsel) | Sale | 6,200 | 60.78 | 376,836 |
| 2021-06-01 | Dorny D Matthew (General Counsel) | Option Ex | 6,200 | 30.63 | 189,906 |
| 2021-05-21 | Thomas James D (Chief Accounting Officer) | Sale | 10,619 | 60.00 | 637,140 |
| 2021-05-21 | Thomas James D (Chief Accounting Officer) | Option Ex | 9,002 | 30.45 | 274,110 |
| 2021-05-11 | Dorny D Matthew (General Counsel) | Sale | 6,200 | 58.88 | 365,056 |
| 2021-05-11 | Dorny D Matthew (General Counsel) | Option Ex | 6,200 | 30.63 | 189,906 |
| 2021-05-06 | Lawrence Mark H (Chief Financial Officer) | Sale | 500 | 55.00 | 27,500 |
| 2021-04-27 | Lawrence Mark H (Chief Financial Officer) | Sale | 800 | 55.02 | 44,016 |
| 2021-04-01 | Dorny D Matthew (General Counsel) | Sale | 6,200 | 53.16 | 329,592 |
| 2021-04-01 | Dorny D Matthew (General Counsel) | Option Ex | 6,200 | 30.63 | 189,906 |
| 2021-03-15 | Napierski Ryan S (President) | Sale | 10,000 | 52.65 | 526,470 |
| 2021-03-15 | Napierski Ryan S (President) | Option Ex | 10,000 | 30.63 | 306,300 |
| 2021-03-09 | Chang Joseph Y (Chief Scientific Officer) | Sale | 626 | 51.55 | 32,270 |
| 2021-03-01 | Dorny D Matthew (General Counsel) | Sale | 12,400 | 52.12 | 646,288 |
| 2021-03-01 | Dorny D Matthew (General Counsel) | Option Ex | 12,400 | 30.63 | 379,812 |
| 2021-02-18 | Chang Joseph Y (Chief Scientific Officer) | Sale | 1,125 | 49.77 | 55,991 |
| 2021-02-18 | Campbell Daniel W | Buy | 10,110 | 49.48 | 500,293 |
| 2021-02-17 | Campbell Daniel W | Buy | 9,910 | 50.65 | 501,891 |
| 2021-02-17 | Lund Steven (Exec. Chairman of the Board) | Buy | 20,850 | 48.05 | 1,001,842 |
| 2021-02-16 | Napierski Ryan S (President) | Sale | 7,000 | 49.56 | 346,920 |
| 2021-02-16 | Napierski Ryan S (President) | Option Ex | 7,000 | 30.63 | 214,410 |
| 2021-01-20 | Napierski Ryan S (President) | Sale | 10,156 | 59.12 | 600,422 |
| 2021-01-20 | Napierski Ryan S (President) | Option Ex | 8,400 | 30.63 | 257,292 |
| 2021-01-15 | Napierski Ryan S (President) | Sale | 7,000 | 55.45 | 388,150 |
| 2021-01-15 | Napierski Ryan S (President) | Option Ex | 7,000 | 30.63 | 214,410 |
| 2021-01-07 | Napierski Ryan S (President) | Sale | 4,844 | 59.05 | 286,038 |
| 2021-01-07 | Napierski Ryan S (President) | Option Ex | 1,600 | 30.63 | 49,008 |
| 2021-01-04 | Dorny D Matthew (General Counsel) | Sale | 6,200 | 55.22 | 342,333 |
| 2021-01-04 | Dorny D Matthew (General Counsel) | Option Ex | 6,200 | 30.63 | 189,906 |
| 2020-12-15 | Napierski Ryan S (President) | Sale | 7,000 | 50.97 | 356,790 |
| 2020-12-15 | Napierski Ryan S (President) | Option Ex | 7,000 | 30.63 | 214,410 |
| 2020-12-01 | Lawrence Mark H (Chief Financial Officer) | Sale | 3,993 | 50.61 | 202,085 |
| 2020-12-01 | Dorny D Matthew (General Counsel) | Sale | 6,200 | 51.39 | 318,599 |
| 2020-12-01 | Dorny D Matthew (General Counsel) | Option Ex | 6,200 | 30.63 | 189,906 |
| 2020-11-17 | Woodbury Edwina D | Sale | 2,500 | 53.16 | 132,900 |
| 2020-11-16 | Napierski Ryan S (President) | Sale | 7,000 | 51.99 | 363,930 |
| 2020-11-16 | Napierski Ryan S (President) | Option Ex | 7,000 | 30.63 | 214,410 |
| 2020-11-11 | Dorny D Matthew (General Counsel) | Sale | 6,200 | 50.51 | 313,180 |
| 2020-11-11 | Dorny D Matthew (General Counsel) | Option Ex | 6,200 | 30.63 | 189,906 |
| 2020-10-15 | Napierski Ryan S (President) | Sale | 7,000 | 54.67 | 382,690 |
| 2020-10-15 | Napierski Ryan S (President) | Option Ex | 7,000 | 30.63 | 214,410 |
| 2020-10-02 | Napierski Ryan S (President) | Sale | 10,000 | 55.30 | 552,970 |
| 2020-10-02 | Napierski Ryan S (President) | Option Ex | 10,000 | 30.63 | 306,300 |
| 2020-09-24 | Napierski Ryan S (President) | Sale | 22,000 | 51.18 | 1,125,960 |
| 2020-09-24 | Napierski Ryan S (President) | Option Ex | 17,000 | 30.63 | 520,710 |
| 2020-09-23 | Dorny D Matthew (General Counsel) | Sale | 6,200 | 52.07 | 322,834 |
| 2020-09-23 | Dorny D Matthew (General Counsel) | Option Ex | 6,200 | 30.63 | 189,906 |
| 2020-09-10 | Chang Joseph Y (Chief Scientific Officer) | Sale | 6,869 | 51.09 | 350,902 |
| 2020-09-10 | Chang Joseph Y (Chief Scientific Officer) | Option Ex | 1,761 | 39.51 | 69,577 |
| 2020-09-09 | Chang Joseph Y (Chief Scientific Officer) | Sale | 9,931 | 49.92 | 495,755 |
| 2020-09-09 | Chang Joseph Y (Chief Scientific Officer) | Option Ex | 5,039 | 39.51 | 199,090 |
| 2020-08-17 | Napierski Ryan S (President) | Sale | 5,000 | 47.24 | 236,200 |
| 2020-06-05 | Chang Joseph Y (Chief Scientific Officer) | Sale | 34,970 | 40.01 | 1,399,149 |
| 2020-03-20 | Wood Ritch N (Chief Executive Officer) | Buy | 10,000 | 20.25 | 202,500 |
| 2019-05-21 | Offen Neil H (Director) | Option Ex | 5,000 | 43.20 | 216,000 |
| 2019-05-21 | Andersen Nevin N (Director) | Option Ex | 5,000 | 43.20 | 216,000 |
| 2019-05-21 | Lipman Andrew D (Director) | Option Ex | 5,000 | 43.20 | 216,000 |
| 2019-05-21 | Campbell Daniel W (Director) | Option Ex | 5,000 | 43.20 | 216,000 |
| 2019-05-18 | Andersen Nevin N (Director) | Option Ex | 5,000 | 13.77 | 68,850 |
| 2019-05-18 | Lipman Andrew D (Director) | Option Ex | 5,000 | 13.77 | 68,850 |
| 2019-02-27 | Andersen Nevin N (Director) | Option Ex | 10,100 | 9.40 | 94,940 |
| 2019-02-27 | Lipman Andrew D (Director) | Option Ex | 10,100 | 9.40 | 94,940 |
| 2019-02-09 | Dorny D Matthew (General Counsel) | Option Ex | 13,750 | 54.08 | 743,600 |
| 2019-02-09 | Wood Ritch N (Chief Executive Officer) | Option Ex | 31,250 | 54.08 | 1,690,000 |
| 2019-02-09 | Chang Joseph Y (Chief Scientific Officer) | Option Ex | 7,500 | 54.08 | 405,600 |
| 2019-01-02 | Dorny D Matthew (General Counsel) | Sale | 1,250 | 60.60 | 75,750 |
| 2019-01-02 | Dorny D Matthew (General Counsel) | Option Ex | 1,250 | 30.63 | 38,287 |
| 2018-12-03 | Dorny D Matthew (General Counsel) | Sale | 2,500 | 67.63 | 169,075 |
| 2018-12-03 | Dorny D Matthew (General Counsel) | Option Ex | 2,500 | 30.63 | 76,575 |
| 2018-11-12 | Dorny D Matthew (General Counsel) | Sale | 2,500 | 65.38 | 163,450 |
| 2018-11-12 | Dorny D Matthew (General Counsel) | Option Ex | 2,500 | 30.63 | 76,575 |
Insider trading activities including stock purchases, stock sales, and option exercises of NUS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nu Skin Enterprises, Inc. (symbol NUS, CIK number 1021561) see the Securities and Exchange Commission (SEC) website.